GK
Gaurav Kharya
About Gaurav Kharya
Data last updated:
Gaurav Kharya is a Director at Cellogen Therapeutics Private Limited (since 2021) and Director at Chimera Transplant Solution Private Limited (since 2018). The companies operate in Life Sciences, Non-Profit Organizations and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹54.3 Lakh; the largest is Cellogen Therapeutics Private Limited at ₹46.1 Lakh (FY 2025). Earlier, Gaurav Kharya was a Director at Alpine Lifescience Private Limited (2019–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cellogen Therapeutics Private Limited U85300UP2021PTC202881 | Director | 08 Jun 2021 | 2021 | ₹46.1 Lakh (FY 2025) | Active |
 Chimera Transplant Solution Private Limited U85320DL2018PTC334748 | Director | 01 Jun 2018 | 2018 | ₹8.2 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Alpine Lifescience Private Limited U24230DL2019PTC354342 | Director | 28 Aug 2019 | 2019 | ₹1.61 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Gaurav Kharya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Tanveer Ahmad | 09724780 | Cellogen Therapeutics Private Limited | Director |
| Nidhi Gupta | 08534858 | Chimera Transplant Solution Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gaurav Kharya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gaurav Kharya
Gaurav Kharya currently holds 2 directorships: Cellogen Therapeutics Private Limited (Director, since 08 Jun 2021, revenue ₹46.1 Lakh (FY 2025)); Chimera Transplant Solution Private Limited (Director, since 01 Jun 2018, revenue ₹8.2 Lakh (FY 2025)).
Gaurav Kharya was first appointed on 01 Jun 2018 as Director at Chimera Transplant Solution Private Limited. The most recent appointment on record is 08 Jun 2021 at Cellogen Therapeutics Private Limited.
The 2 current companies of Gaurav Kharya that report revenue have a combined latest revenue of ₹54.3 Lakh: Cellogen Therapeutics Private Limited ₹46.1 Lakh (FY 2025); Chimera Transplant Solution Private Limited ₹8.2 Lakh (FY 2025).
Gaurav Kharya held 1 earlier board appointment: Alpine Lifescience Private Limited (Director, 28 Aug 2019 to 18 Jun 2020).
The current boards of Gaurav Kharya's companies include Tanveer Ahmad (Cellogen Therapeutics Private Limited), Nidhi Gupta (Chimera Transplant Solution Private Limited).